South & Central America Neurorehabilitation Devices Market Forecast to 2031- Regional Analysis - by Product Type (Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, and Wearable Devices), Application (Stroke, Traumatic Brain Injury,

The South & Central America neurorehabilitation devices market was valued at US$ 104.24 million in 2023 and is expected to reach US$ 221.17 million by 2031; it is estimated to register a CAGR of 9.9% from 2023 to 2031.

Strategic Initiatives by Market Players Fuel South & Central America Neurorehabilitation Devices Market

Strategic initiatives taken by market players, such as mergers, acquisitions, partnerships, and collaborations, are likely to accelerate innovation, develop expertise, and expand market reach.

In April 2022, Blackrock Neurotech partnered with Phantom Neuro, a neurotech startup, to carry out R&D for Phantom Neuro’s patent-pending Phantom X system, which offers patients highly accurate, almost real-time control of current and next-generation assistive devices, such as prosthetics and exoskeletons. This R&D partnership allows Phantom to use Blackrock's decades of experience in neurotechnology and develop biocompatible implantable sensors to complement and bolster the Phantom X platform.

In December 2022, Ekso Bionics—a leader in exoskeleton technology for medical use—announced the acquisition of the Human Motion and Control (“HMC”) Business Unit from Parker Hannifin Corporation. This acquisition will enhance Ekso’s product portfolio and improve its strategic relationships with commercial and research partners such as Vanderbilt University. The partnership with Vanderbilt is expected to enhance its research capabilities and product development.

Thus, the strategic initiatives taken by the market players are likely to create lucrative opportunities for the neurorehabilitation market in the near future.

South & Central America Neurorehabilitation Devices Market Overview

The South & Central America neurorehabilitation devices market is segmented into Brazil, Argentina, and the Rest of South & Central America and Brazil hold the largest market share. The prevalence of a few neurological diseases has been associated with the aging population in Brazil. According to the Pan American Health Organization in 2022, the country has more than 30 million older adults aged 60 years and above, representing 13% of the country's population. By 2030, the number of people from this age group will reach nearly 50 million, which will be 24% of the total Brazilian population. The World Health Organization (WHO) and the Brazilian Institute of Geography and Statistics reported that the geriatric population in Brazil (aged 60 years and older) is expected to reach ~55 million by 2040. Thus, the increasing incidences of neurological diseases, such as Parkinson's disease, are likely to propel the demand for neurorehabilitation in the coming years. Many institutes in Brazil are working toward the growth of neuroscience in Brazil.

South & Central America Neurorehabilitation Devices Market Revenue and Forecast to 2031 (US$ Million)

South & Central America Neurorehabilitation Devices Market Segmentation

The South & Central America neurorehabilitation devices market is categorized into product type, application, end user, and country.

By product type, the South & Central America neurorehabilitation devices market is segmented into neurorobotic system, brain computer interface, non-invasive stimulators, and wearable devices. The brain computer interface segment held the largest share of the South & Central America neurorehabilitation devices market share in 2023.

In terms of application, the South & Central America neurorehabilitation devices market is segmented into stroke, traumatic brain injury, spinal cord injury, Parkinson's Disease, cerebral palsy, and others. The stroke segment held the largest share of the South & Central America neurorehabilitation devices market share in 2023.

By end user, the South & Central America neurorehabilitation devices market is segmented into rehabilitation centers, hospitals & clinics, and home care. The hospitals & clinics segment held the largest share of the South & Central America neurorehabilitation devices market share in 2023.

Based on country, the South & Central America neurorehabilitation devices market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil segment held the largest share of South & Central America neurorehabilitation devices Market in 2023.

Abbott Laboratories; BIONIK; BioXtreme Ltd; Blackrock Microsystems Inc; Ekso Bionics Holdings Inc; EMOTIV; Hocoma AG; Medtronic Plc; Renishaw Plc; and Tyromotion GmbH are some of the leading companies operating in the South & Central America neurorehabilitation devices market.

Reasons to buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America neurorehabilitation devices market.
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America neurorehabilitation devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America neurorehabilitation devices market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution. Show more